+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Eurocine Vaccines AB (EUCI) - Financial and Strategic SWOT Analysis Review

  • ID: 1322626
  • SWOT Analysis
  • March 2018
  • Region: Global
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Eurocine Vaccines AB (Eurocine) is a developer of nasal influenza vaccines. The company offers products which include Immunose FLU, a safe and effective influenza vaccine for children. It holds two proprietary adjuvant systems such as Endocine, and a Cationic System, which can be used for nasal vaccination. Eurocine uses clinically validated technology Endocine to develop protected nasal influenza vaccine for needle-free and convenient nasal vaccination in children. The company also develops nasal pneumococcal vaccines that enhance the immune response through stimulation of mucosal immunity. It also out-licenses Immunose FLU for clinical development and commercialization. Eurocine is headquartered in Stockholm, Sweden.

Eurocine Vaccines AB Key Recent Developments

Apr 07, 2017: Eurocine Vaccines strengthens organization to develop influenza vaccine

This comprehensive SWOT profile of Eurocine Vaccines AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Eurocine Vaccines AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Eurocine Vaccines AB - Key Information
  • Eurocine Vaccines AB - Overview
  • Eurocine Vaccines AB - Key Employees
  • Eurocine Vaccines AB - Key Employee Biographies
  • Eurocine Vaccines AB - Key Operational Heads
  • Eurocine Vaccines AB - Major Products and Services
  • Eurocine Vaccines AB - History
  • Eurocine Vaccines AB - Company Statement
  • Eurocine Vaccines AB - Locations And Subsidiaries
  • Eurocine Vaccines AB - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Eurocine Vaccines AB - Business Description
  • Eurocine Vaccines AB - Corporate Strategy
  • Eurocine Vaccines AB - SWOT Analysis
  • SWOT Analysis - Overview
  • Eurocine Vaccines AB - Strengths
  • Eurocine Vaccines AB - Weaknesses
  • Eurocine Vaccines AB - Opportunities
  • Eurocine Vaccines AB - Threats
  • Eurocine Vaccines AB - Key Competitors
Section 3 - Company Financial Performance Charts
  • Eurocine Vaccines AB - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Eurocine Vaccines AB, Key Information
  • Eurocine Vaccines AB, Key Ratios
  • Eurocine Vaccines AB, Share Data
  • Eurocine Vaccines AB, Major Products and Services
  • Eurocine Vaccines AB, History
  • Eurocine Vaccines AB, Key Employees
  • Eurocine Vaccines AB, Key Employee Biographies
  • Eurocine Vaccines AB, Key Operational Heads
  • Eurocine Vaccines AB, Other Locations
  • Eurocine Vaccines AB, Subsidiaries
  • Eurocine Vaccines AB, Key Manufacturing facilities
  • Eurocine Vaccines AB, Key Competitors
  • Eurocine Vaccines AB, SWOT Analysis
  • Eurocine Vaccines AB, Ratios based on current share price
  • Eurocine Vaccines AB, Annual Ratios
  • Eurocine Vaccines AB, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Eurocine Vaccines AB, Performance Chart
  • Eurocine Vaccines AB, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3